false
Catalog
Updates in Treating Tobacco Use Disorder
Presentation Slides
Presentation Slides
Back to course
Pdf Summary
This document is an update on treating tobacco use disorder through an initiative by the American Psychiatric Association (APA) and Substance Abuse and Mental Health Services Administration (SAMHSA). The initiative aims to provide support and education regarding the treatment of tobacco use disorder in individuals with serious mental illness. Funding for the initiative is provided by SAMHSA.<br /><br />The document highlights the importance of addressing tobacco use as a co-occurring disorder and the need for integrated mental health and addiction services. It emphasizes the effectiveness of brief interventions, counseling, and medications in treating tobacco use disorder. The use of nicotine replacement therapy (NRT), such as patches, gum, and inhalers, is discussed, as well as the medications bupropion and varenicline. The document also mentions the safety and effectiveness of these medications, potential medication interactions with tobacco smoke, and the benefits of combination NRT therapy.<br /><br />The document emphasizes the prevalence and consequences of tobacco use in individuals with serious mental illness. It discusses the social justice issues related to smoking, including financial hardships, employment difficulties, and poorer mental health. The document also mentions the public health interventions aimed at reducing smoking rates, such as anti-smoking advertisements and tobacco-free laws.<br /><br />Additionally, the document provides information on the epidemiology of tobacco use, the pharmacology of nicotine, and tobacco withdrawal symptoms. It highlights the importance of screening and providing tobacco cessation counseling and services in mental health treatment facilities.<br /><br />Overall, the document provides an overview of the importance of addressing tobacco use disorder in individuals with serious mental illness and offers recommendations for treatment and support. It emphasizes the need for integrated care, effective interventions, and the use of medications in managing tobacco use disorder.
Keywords
American Psychiatric Association
Substance Abuse and Mental Health Services Administration
tobacco use disorder
serious mental illness
integrated mental health services
nicotine replacement therapy
bupropion
varenicline
tobacco cessation counseling
public health interventions
Funding for SMI Adviser was made possible by Grant No. SM080818 from SAMHSA of the U.S. Department of Health and Human Services (HHS). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, SAMHSA/HHS or the U.S. Government.
×
Please select your language
1
English